Friday, July 26, 2024 AIDS 2024: Long-Acting Injectables, Bi-Directional Learning, PACHA & More (VIDEO) Office of Infectious Disease and HIV/AIDS Policy's Kaye Hayes and Director of the National Institute of Allergy and Infectious Diseases at NIH, Dr. Jeanne Marrazzo reflect on key moments from AIDS 2024. Credit: HIV.gov Check out the NIAID blog for the latest updates from AIDS 2024 covering long-acting injectables, bi-directional learning, PACHA & more. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107